Press Releases

  1. Home
  2. Investors
  3. Press Releases
Check-Cap Announces Presentation Evaluating Ingestible Capsule for Preparation-Free Colorectal Cancer Screening at Digestive Disease Week® 2016

ISFIYA, Israel, and BOSTON, May 17, 2016 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening, today announced a podium presentation entitled "A Novel Preparation-Free X-Ray Imaging Capsule for Colon Cancer Screening" will be delivered at Digestive Disease Week® (DDW) 2016. The conference is taking place in San Diego from May 21-24.

Prof. Nadir Arber, M.D., Director of the Integrated Cancer Prevention Center (ICPC) at Tel Aviv Sourasky Medical Center, and a leading investigator in the Company's multicenter study, will present on May 21 from 10:45 a.m.11:00 a.m. in room 31A.  

About Check-Cap

Check-Cap is a clinical stage company developing the world's first diagnostic system for preparation-free examination of the colon to identify precancerous polyps and cancers.

Utilizing proprietary, ultra-low-dose x-ray technology, the system scans the colon in its natural state and creates three-dimensional images of the inner surface. Without requiring traditional bowel cleansing or modifications to a person's diet and activities, Check-Cap's system is designed to address the most significant barriers to colonoscopy and increase adherence with colorectal cancer screening recommendations. The Check-Cap system is currently not cleared for marketing in any jurisdiction.

David Carey
Lazar Partners Ltd.

Rob Sawyer
Lazar Partners Ltd.

SOURCE Check-Cap Ltd.